drugset / Trial / NCT01429701
Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Dermatitis eczematous is a recurrent pruritic skin disorder which has a significant morbidity and impaired quality of life due specially pruritus and physical visible skin lesions. The purpose of this trial is evaluate the effectiveness of two different topic associations of drugs.
Timeline
- Start
- 2012-05
- Primary completion
- 2012-06
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benzocaine | Small molecule | — | Topical |
| Comparator | Betamethasone | Other / unclassified | — | Topical |
| Subject | Clioquinol | Small molecule | — | Topical |
| Comparator | Gentamicin | Small molecule | — | Topical |
| Subject | Polymyxin B | Peptide | — | Topical |
| Subject | Prednisolone | Other / unclassified | — | Topical |
| Comparator | Tolnaftate | Small molecule | — | Topical |
| Comparator | betamethasone + gentamicin + tolnaftato + cleoquinol | Unknown | — | Topical |